Literature DB >> 17245405

KATP channel mutation confers risk for vein of Marshall adrenergic atrial fibrillation.

Timothy M Olson1, Alexey E Alekseev, Christophe Moreau, Xiaoke K Liu, Leonid V Zingman, Takashi Miki, Susumu Seino, Samuel J Asirvatham, Arshad Jahangir, Andre Terzic.   

Abstract

BACKGROUND: A 53-year-old female presented with a 10-year history of paroxysmal atrial fibrillation (AF), precipitated by activity and refractory to medical therapy. In the absence of traditional risk factors for disease, a genetic defect in electrical homeostasis underlying stress-induced AF was explored. INVESTIGATIONS: Echocardiography, cardiac perfusion stress imaging, invasive electrophysiology with isoproterenol provocation, genomic DNA sequencing of K(ATP) channel genes, exclusion of mutation in 2,000 individuals free of AF, reconstitution of channel defect with molecular phenotyping, and verification of pathogenic link in targeted knockout. DIAGNOSIS: K(ATP) channelopathy caused by missense mutation (Thr1547Ile) of the ABCC9 gene conferring predisposition to adrenergic AF originating from the vein of Marshall. MANAGEMENT: Disruption of arrhythmogenic gene-environment substrate at the vein of Marshall by radiofrequency ablation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17245405      PMCID: PMC2013306          DOI: 10.1038/ncpcardio0792

Source DB:  PubMed          Journal:  Nat Clin Pract Cardiovasc Med        ISSN: 1743-4297


  18 in total

1.  Kir6.2 is required for adaptation to stress.

Authors:  Leonid V Zingman; Denice M Hodgson; Peter H Bast; Garvan C Kane; Carmen Perez-Terzic; Richard J Gumina; Darko Pucar; Martin Bienengraeber; Petras P Dzeja; Takashi Miki; Susumu Seino; Alexey E Alekseev; Andre Terzic
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

2.  ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating.

Authors:  Martin Bienengraeber; Timothy M Olson; Vitaliy A Selivanov; Eva C Kathmann; Fearghas O'Cochlain; Fan Gao; Amy B Karger; Jeffrey D Ballew; Denice M Hodgson; Leonid V Zingman; Yuan-Ping Pang; Alexey E Alekseev; Andre Terzic
Journal:  Nat Genet       Date:  2004-03-21       Impact factor: 38.330

3.  A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K+ channels.

Authors:  N Inagaki; T Gonoi; J P Clement; C Z Wang; L Aguilar-Bryan; J Bryan; S Seino
Journal:  Neuron       Date:  1996-05       Impact factor: 17.173

4.  Intramolecular interaction of SUR2 subtypes for intracellular ADP-Induced differential control of K(ATP) channels.

Authors:  Kenji Matsushita; Kengo Kinoshita; Tetsuro Matsuoka; Akikazu Fujita; Takashi Fujikado; Yasuo Tano; Haruki Nakamura; Yoshihisa Kurachi
Journal:  Circ Res       Date:  2002-03-22       Impact factor: 17.367

5.  Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation.

Authors:  Timothy M Olson; Alexey E Alekseev; Xiaoke K Liu; Sungjo Park; Leonid V Zingman; Martin Bienengraeber; Srinivasan Sattiraju; Jeffrey D Ballew; Arshad Jahangir; Andre Terzic
Journal:  Hum Mol Genet       Date:  2006-06-13       Impact factor: 6.150

6.  Mechanosensitive gating of atrial ATP-sensitive potassium channels.

Authors:  D R Van Wagoner
Journal:  Circ Res       Date:  1993-05       Impact factor: 17.367

Review 7.  Epidemiology and natural history of atrial fibrillation: clinical implications.

Authors:  S S Chugh; J L Blackshear; W K Shen; S C Hammill; B J Gersh
Journal:  J Am Coll Cardiol       Date:  2001-02       Impact factor: 24.094

8.  Decreased ATP-sensitive K(+) current density during chronic human atrial fibrillation.

Authors:  Bartosz Balana; Dobromir Dobrev; Erich Wettwer; Torsten Christ; Michael Knaut; Ursula Ravens
Journal:  J Mol Cell Cardiol       Date:  2003-12       Impact factor: 5.000

9.  Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes.

Authors:  Michel Haïssaguerre; Fabrice Extramiana; Mélèze Hocini; Bruno Cauchemez; Pierre Jaïs; Jose Angel Cabrera; Jerónimo Farré; Gerónimo Farre; Antoine Leenhardt; Prashanthan Sanders; Christophe Scavée; Li-Fern Hsu; Rukshen Weerasooriya; Dipen C Shah; Robert Frank; Philippe Maury; Marc Delay; Stéphane Garrigue; Jacques Clémenty
Journal:  Circulation       Date:  2003-08-18       Impact factor: 29.690

10.  KCNQ1 gain-of-function mutation in familial atrial fibrillation.

Authors:  Yi-Han Chen; Shi-Jie Xu; Said Bendahhou; Xiao-Liang Wang; Ying Wang; Wen-Yuan Xu; Hong-Wei Jin; Hao Sun; Xiao-Yan Su; Qi-Nan Zhuang; Yi-Qing Yang; Yue-Bin Li; Yi Liu; Hong-Ju Xu; Xiao-Fei Li; Ning Ma; Chun-Ping Mou; Zhu Chen; Jacques Barhanin; Wei Huang
Journal:  Science       Date:  2003-01-10       Impact factor: 47.728

View more
  73 in total

1.  K(ATP) channels process nucleotide signals in muscle thermogenic response.

Authors:  Santiago Reyes; Sungjo Park; Andre Terzic; Alexey E Alekseev
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-10-07       Impact factor: 8.250

Review 2.  ABCC9/SUR2 in the brain: Implications for hippocampal sclerosis of aging and a potential therapeutic target.

Authors:  Peter T Nelson; Gregory A Jicha; Wang-Xia Wang; Eseosa Ighodaro; Sergey Artiushin; Colin G Nichols; David W Fardo
Journal:  Ageing Res Rev       Date:  2015-07-28       Impact factor: 10.895

Review 3.  KATP Channels in the Cardiovascular System.

Authors:  Monique N Foster; William A Coetzee
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

4.  KATP channels confer survival advantage in cocaine overdose.

Authors:  S Reyes; G C Kane; T Miki; S Seino; A Terzic
Journal:  Mol Psychiatry       Date:  2007-12       Impact factor: 15.992

Review 5.  K(ATP) channel pharmacogenomics: from bench to bedside.

Authors:  S Sattiraju; S Reyes; G C Kane; A Terzic
Journal:  Clin Pharmacol Ther       Date:  2007-10-24       Impact factor: 6.875

6.  Ion channel mutations in AF: signal or noise?

Authors:  Patrick T Ellinor; Calum A MacRae
Journal:  Heart Rhythm       Date:  2008-01-17       Impact factor: 6.343

7.  Interaction of asymmetric ABCC9-encoded nucleotide binding domains determines KATP channel SUR2A catalytic activity.

Authors:  Sungjo Park; Bernard B C Lim; Carmen Perez-Terzic; Georges Mer; Andre Terzic
Journal:  J Proteome Res       Date:  2008-03-01       Impact factor: 4.466

8.  Dominant missense mutations in ABCC9 cause Cantú syndrome.

Authors:  Magdalena Harakalova; Jeske J T van Harssel; Paulien A Terhal; Stef van Lieshout; Karen Duran; Ivo Renkens; David J Amor; Louise C Wilson; Edwin P Kirk; Claire L S Turner; Debbie Shears; Sixto Garcia-Minaur; Melissa M Lees; Alison Ross; Hanka Venselaar; Gert Vriend; Hiroki Takanari; Martin B Rook; Marcel A G van der Heyden; Folkert W Asselbergs; Hans M Breur; Marielle E Swinkels; Ingrid J Scurr; Sarah F Smithson; Nine V Knoers; Jasper J van der Smagt; Isaac J Nijman; Wigard P Kloosterman; Mieke M van Haelst; Gijs van Haaften; Edwin Cuppen
Journal:  Nat Genet       Date:  2012-05-18       Impact factor: 38.330

9.  Embryonic stem cell therapy of heart failure in genetic cardiomyopathy.

Authors:  Satsuki Yamada; Timothy J Nelson; Ruben J Crespo-Diaz; Carmen Perez-Terzic; Xiao-Ke Liu; Takashi Miki; Susumu Seino; Atta Behfar; Andre Terzic
Journal:  Stem Cells       Date:  2008-07-31       Impact factor: 6.277

Review 10.  KATP channels and cardiovascular disease: suddenly a syndrome.

Authors:  Colin G Nichols; Gautam K Singh; Dorothy K Grange
Journal:  Circ Res       Date:  2013-03-29       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.